QuadMedicine Inc
464490
Company Profile
Business description
QuadMedicine Inc is engaged in developing pharmaceutical microneedles. The company focuses on a drug delivery system using microneedle technology that enables the transdermal delivery of vaccines and synthetic drugs, replacing intramuscular and subcutaneous injections.
Contact
14, Sagimak-gol-ro 45beongil
6th floor, Jebi-605
Sangdaewon-dong, Urim Lions Valley 2nd,Jungwon-gu
Gyeonggi-do
Seongnam-si
KORT: +82 317541152
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
Employees
89
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,421.80 | 15.60 | -0.17% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,866.51 | 198.48 | 0.77% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,890.30 | 1,283.59 | 1.96% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,231.40 | 18.20 | -0.20% |
| SSE Composite Index | 3,948.72 | 8.68 | 0.22% |